Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3C.L Regulatory News (K3C)

  • There is currently no data for K3C

Trading Update

12 Dec 2022 07:00

RNS Number : 2989J
K3 Capital Group PLC
12 December 2022
 

12th December 2022

K3 CAPITAL GROUP PLC

("K3", the "Company" and including its subsidiaries the "Group")

Trading Update

K3 Capital Group plc, a multi-disciplinary and complementary group providing specialist advisory services to SMEs, is pleased to provide a trading update for the six-month period ended 30 November 2022.

The Group delivered a good performance during the first six months of FY23 and is expecting to report revenues in the region of £42 million (H1 FY22: £31.2m) delivering profits which are comfortably in line with the Board's expectations.

The Group maintains encouraging activity levels and pipelines across its brands for the second half of the year and management is confident in meeting the Board's expectations for the full year.

John Rigby, K3's CEO, commented,

"The first six months of the year have been positive for K3C especially when taking into account the wide variety of challenges created by global events and the UK macro-economic environment. Our Q1 momentum has been maintained as we continue to deliver our growth strategy. The results are underpinned by diversified revenue streams and illustrate the benefits of our strategy of building a broader SME services group with greater visibility of future revenues.

I am particularly pleased with the performance of the Business Sales Division. Despite the market headwinds, it has continued to grow and deliver strong results which includes some sizeable completions in H1 within our Corporate Finance function.

Our Restructuring Division continues to see an uptick in activity levels and this is clearly a strong indicator of growing demand as the headwinds seen across the restructuring market now turn to tailwinds. As has been widely reported, the slower than expected return of the higher value administration work has resulted in a moderation in growth rates and margins. However, we would hope to see this improve as we look further forward.

Whilst the Chancellor's recent changes to the R&D scheme for SMEs were clearly not welcomed, we continue to drive client numbers within our Tax Division and we are hopeful that the negative impacts of the changes can be potentially offset by our continued organic growth.

The Board continues to look for complementary acquisitions within the professional services space. While cognisant of the negative outlook for the UK economy, we remain confident in the prospects of the Group for the remainder of FY23."

ends

 

For further information, please contact:

K3 Capital Group PLC

John Rigby, Chief Executive Officer

c/o Numis +44 (0)20 7260 1000

Andrew Melbourne, Chief Financial Officer

 

Numis (Nominated Adviser and Corporate Broker)

Stuart Skinner

William Wickham

 

+44 (0)20 7260 1000

 

Alma PR

Josh Royston

Hilary Buchanan

Sam Modlin

 

+44 (0)20 3405 0205

 

About K3 

K3 Capital Group plc (AIM:K3C) is a multi-disciplinary and complementary group providing specialist advisory services to SMEs, incorporating Business and Company Sales, Restructuring and Insolvency and Tax Advisory services. The Group floated on the London Stock Exchange's Alternative Investment Market (AIM) in April 2017.

Services provided by the Group fall into three key operating divisions:

Business Sales Division:

· Company sales and business brokerage

· Corporate finance services

· Transaction services

· Debt advisory 

Tax Division:

· Research and development tax credit advisory

· Tax investigations

· Tax planning

· Tax advisory 

Restructuring Division:

· Restructuring advisory

· Financial advisory

· Creditor services

· Forensic accounting and expert witness

· Pensions advisory

· Accelerated M&A

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTLFLLFLLLLFBV
Date   Source Headline
7th Sep 20207:00 amRNSInvestor Presentation
7th Aug 20202:36 pmRNSHolding(s) in Company
7th Aug 202011:26 amRNSHolding(s) in Company
3rd Aug 20207:00 amRNSAcquisition, Directorate Changes & Results Notice
21st Jul 20204:32 pmRNSHolding(s) in Company
21st Jul 20202:51 pmRNSHolding(s) in Company
20th Jul 20203:51 pmRNSHolding(s) in Company
20th Jul 20202:35 pmRNSHolding(s) in Company
17th Jul 202011:30 amRNSResult of General Meeting
2nd Jul 20205:40 pmRNSHolding(s) in Company
2nd Jul 20205:37 pmRNSHolding(s) in Company
1st Jul 20202:37 pmRNSHolding(s) in Company
1st Jul 202011:59 amRNSHolding(s) in Company
30th Jun 20202:00 pmRNSPosting of Circular and Notice of General Meeting
29th Jun 20202:05 pmRNSSecond Price Monitoring Extn
29th Jun 20202:00 pmRNSPrice Monitoring Extension
29th Jun 20201:25 pmRNSResult of Fundraising
29th Jun 20207:01 amRNSPrimaryBid.com Offers
29th Jun 20207:00 amRNSProposed Fundraising to Raise up to £30.5 million
7th Apr 20204:42 pmRNSSecond Price Monitoring Extn
7th Apr 20204:36 pmRNSPrice Monitoring Extension
6th Apr 20207:00 amRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSTrading Update
10th Mar 20202:00 pmRNSDirector/PDMR Shareholding
28th Feb 202011:00 amRNSPrice Monitoring Extension
19th Feb 20203:00 pmRNSDirector/PDMR Shareholding
5th Feb 20202:30 pmRNSDirector/PDMR Shareholding
4th Feb 20207:00 amRNSHalf-year Report
16th Dec 20197:00 amRNSTrading Update
20th Nov 20196:05 pmRNSHolding(s) in Company
18th Oct 20191:30 pmRNSResult of AGM
17th Sep 20191:43 pmRNSFinal Dividend Timetable
17th Sep 20197:00 amRNSNotice of AGM
17th Sep 20197:00 amRNSFinal Results
21st Aug 201910:25 amRNSHolding(s) in Company
17th Jun 201912:00 pmRNSCorrection: Director/PDMR Shareholding
14th Jun 20192:40 pmRNSDirector/PDMR Shareholding
6th Jun 20192:09 pmRNSDirector/PDMR Shareholding
5th Jun 20197:00 amRNSTrading Update and Notice of Results
16th May 20194:30 pmRNSHolding(s) in Company
8th Apr 201911:41 amRNSHolding(s) in Company
8th Apr 20197:00 amRNSDirector/PDMR Shareholding
5th Apr 20197:00 amRNSTrading Update
21st Jan 20197:00 amRNSHalf-year Report
12th Dec 20187:00 amRNSLeading Advisor in Mid-Market M&A Adviser Rankings
11th Dec 20187:00 amRNSTrading Update
6th Dec 20184:52 pmRNSHolding(s) in Company
11th Oct 201811:05 amRNSSecond Price Monitoring Extn
11th Oct 201811:00 amRNSPrice Monitoring Extension
26th Sep 20185:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.